Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. To The Board Of Directors
(MENAFN- PR Newswire) WALTHAM, Mass., May 15, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX ), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the appointment of …